SELLAS Life Sciences (SLS) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.89% |
| Dec 31, 2025 | 81.99% |
| Sep 30, 2025 | -662.43% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 13.37% |
| Sep 30, 2024 | 84.39% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 84.71% |
| Dec 31, 2023 | 58.46% |
| Sep 30, 2023 | 21.48% |
| Jun 30, 2023 | 68.82% |
| Mar 31, 2023 | -520.60% |
| Dec 31, 2022 | -455.32% |
| Sep 30, 2022 | 4.55% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 66.14% |
| Dec 31, 2021 | -58.76% |
| Sep 30, 2021 | -540.70% |
| Jun 30, 2021 | 77.34% |
| Mar 31, 2021 | -48.14% |
| Dec 31, 2020 | -40.42% |
| Sep 30, 2020 | 14.02% |
| Jun 30, 2020 | 37.62% |
| Mar 31, 2020 | 82.32% |
| Dec 31, 2019 | 74.52% |
| Sep 30, 2019 | 83.26% |
| Jun 30, 2019 | 82.78% |
| Mar 31, 2019 | -85.89% |
| Dec 31, 2018 | -56.33% |
| Sep 30, 2018 | 85.77% |
| Jun 30, 2018 | 42.52% |
| Mar 31, 2018 | 45.38% |
| Dec 31, 2017 | 18.61% |
| Sep 30, 2017 | 19.41% |
| Jun 30, 2017 | 29.72% |
| Mar 31, 2017 | 29.85% |
| Dec 31, 2016 | 49.80% |
| Sep 30, 2016 | 21.87% |
| Jun 30, 2016 | 2.16% |
| Mar 31, 2016 | 71.59% |
| Dec 31, 2015 | 65.08% |
| Sep 30, 2015 | 12.27% |
| Jun 30, 2015 | -33.04% |
| Mar 31, 2015 | -82.47% |
| Dec 31, 2014 | 20.90% |
| Sep 30, 2014 | -16.24% |
| Jun 30, 2014 | -29.74% |
| Mar 31, 2014 | -67.71% |
| Dec 31, 2013 | -90.70% |
| Sep 30, 2013 | -162.67% |
| Jun 30, 2013 | -60.15% |